Yes, but it is going up obviously for a reason. Revenues have exploded from $2.7 million in Q1, to $4 million in Q2, to $4.8 million in Q3 and showed profitability! Additionally, the main product driving the growth, called FGXpress Powerstrips (also on the FDA medical device list), has not even officially launched yet (coming in late March). Revenues for October alone were approximately the same as Q1 in a press release. Huge upside in my opinion here under $2. Market cap is not even 2014 conservative forecast for sales of $30 million. Jump on board!